Passage Bio, Inc. ( PASG) - Key Metrics
PASG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$2.44 | -$2.86 | -$2.86 |
| 2026Q1 | $0 | -$2.36 | -$4.05 | -$4.05 |
| 2025Q4 | $0 | -$4.09 | -$2.04 | -$2.04 |
| 2025Q3 | $0 | -$2.45 | -$1.53 | -$1.53 |
| 2025Q2 | $0 | -$2.96 | -$2 | -$2 |
PASG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.50 |
| 2026Q1 | 0% | -0.83 |
| 2025Q4 | 0% | -0.72 |
| 2025Q3 | 0% | -0.82 |
| 2025Q2 | 0% | -0.68 |
PASG
Price: $3.72
52 week price:
Earnings Per Share: -11.05 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 271900
Market Capitalization: 13.2 million